OLN324: Why Size May Matter - Top-Institutions - MDSpire

OLN324: Why Size May Matter

David A. Eichenbaum, MD, FASRS, and Veeral S. Sheth, MD, MBA, discuss phase 1 JADE findings and how OLN324's small-format design may contribute to improved retinal drying in nAMD and diabetic macular edema.

  • By

  • David A. Eichenbaum, MD

  • Veeral S. Sheth, MD, MBA, FACS

  • July 15, 2026

  • 3 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Retina Vitreous Associates of Florida
    Retina Vitreous Associates of Florida

    Florida, FL

    Key Differentiators

    • Pharmacology

  • #2

    University Retina
    University Retina

    Chicago, IL

    Key Differentiators

    • Pharmacology

  • #3

    Montpellier Cancer Institute
    Montpellier Cancer Institute

    Montpellier, Occitanie

    Key Differentiators

    • Pharmacology

  • #4

    Flinders Medical Centre
    Flinders Medical Centre

    Adelaide, SA

    Key Differentiators

    • Pharmacology

  • #5

    Cleveland Clinic Cancer Institute
    Cleveland Clinic Cancer Institute

    Cleveland, OH

    Key Differentiators

    • Pharmacology

Original Source(s)

OLN324: Why Size May Matter

  • by David A. Eichenbaum, MD, Veeral S. Sheth, MD, MBA, FACS

  • July 15, 2026

Related Content

Neuroprotection: Retina's Next Frontier?

At OIS Retina in Montreal, Riad Sherif, MD, discussed Oculis’s optic neuritis program and why neuroprotection may represent the next frontier in retinal therapeutics.

Drs. Berrocal Reflect on ASRS 2026

ASRS 2026 meeting program chair Audina M. “Nina” Berrocal, MD, FASRS, joins Maria H. Berrocal, MD, to discuss the meeting’s highlights, surgical sessions, and educational approach.

Applications of dynamic gratings in neuro-ophthalmic disorders